Finasteride is an oral prescription medicine for male pattern hair loss and benign prostatic hyperplasia. It is mainly used by adult men with androgenetic alopecia or an enlarged prostate. By inhibiting 5-alpha reductase, it lowers dihydrotestosterone and can slow hair follicle miniaturisation or reduce prostate growth.
Finasteride is an oral prescription medicine used for male pattern hair loss and benign prostatic hyperplasia. It is intended mainly for adult men with androgenetic alopecia or an enlarged prostate. Finasteride belongs to the 5-alpha reductase inhibitor class.
Finasteride is an oral prescription medicine supplied as pills. It belongs to the 5-alpha reductase inhibitor class and is used for male pattern hair loss or benign prostatic hyperplasia. The prescribed strength depends on the condition being treated; exact product details are stated on the pack and by the prescriber.
The available product is supplied as pills. The exact strength and prescribed schedule should correspond to the indication recorded by the prescriber. Finasteride for male pattern hair loss is prescribed differently from finasteride used for an enlarged prostate.
Typical administration principles include:
Finasteride is absorbed after oral administration and undergoes hepatic metabolism. The medicine is not an instant hair-growth treatment. Assessing hair response usually requires several months of consistent use, while prostate symptom improvement may also take time.
A useful practical distinction is this: reduced shedding can be an early sign of response, but photographs taken under similar lighting are more reliable than daily mirror checks. Hair naturally varies with styling, washing, and humidity.
Finasteride can lower serum prostate-specific antigen, or PSA, in men using it for BPH. A doctor interpreting a PSA result needs to know that finasteride is being taken, because the result may require clinical adjustment.
Finasteride competitively inhibits the type II 5-alpha reductase enzyme. This enzyme converts testosterone into dihydrotestosterone, also called DHT. DHT is a more potent androgen in tissues such as the scalp and prostate.
Lower DHT reduces stimulation of susceptible hair follicles. In male pattern hair loss, this may slow miniaturisation and extend the period during which follicles produce visible hair. In prostate tissue, lower DHT can reduce glandular growth.
The medicine acts on hormone conversion rather than directly stimulating follicles. The US Food and Drug Administration describes finasteride as a selective inhibitor of steroid 5-alpha reductase. The same pharmacological principle explains its use in both androgenetic alopecia and BPH [1].
DHT is not the same as testosterone. Finasteride does not remove testosterone from the body; it reduces conversion of testosterone into DHT in tissues where type II 5-alpha reductase is active.
Finasteride belongs to the 5-alpha reductase inhibitor class. It is supplied as pills and has two established medical roles: treatment of male pattern hair loss and management of benign prostatic hyperplasia, commonly called BPH.
The appropriate strength depends on the condition being treated. Hair loss and prostate symptoms require different prescribing decisions, so a tablet intended for one indication should not be substituted for another without medical direction.
Androgenetic alopecia is a hormone-sensitive form of progressive hair thinning. It commonly affects the temples, frontal hairline, and crown. Finasteride lowers the hormonal signal responsible for gradual follicle miniaturisation, helping preserve existing hair and supporting thicker growth in some men.
Treatment is intended for adult men. Results develop slowly because hair follicles move through growth and resting cycles. A reduction in shedding may appear before visible density improves.
Benign prostatic hyperplasia causes enlargement of the prostate. The enlarged gland can narrow the urinary passage and contribute to a weak stream, hesitancy, frequent urination, or incomplete bladder emptying.
Finasteride reduces DHT activity within prostate tissue. Over time, this can reduce prostate volume and improve lower urinary tract symptoms. It is not designed to provide immediate relief during acute urinary retention.
A urinary blockage requires urgent medical assessment.
Finasteride and minoxidil work through different biological pathways. Dutasteride also inhibits 5-alpha reductase, though it has broader enzyme inhibition and may be selected only after careful clinical assessment.
| Treatment | Main mechanism and route |
|---|---|
| Finasteride | Oral 5-alpha reductase inhibition; lowers DHT |
| Minoxidil | Topical or oral follicle-growth support through a vasodilator-related mechanism |
| Dutasteride | More extensive 5-alpha reductase inhibition; prescription use varies by indication |
Minoxidil does not lower DHT. It acts directly on hair follicles and may help prolong the growth phase. It can cause scalp irritation when applied topically, while oral use requires medical supervision because of possible cardiovascular effects.
Dutasteride inhibits both type I and type II 5-alpha reductase. Its broader action may increase DHT suppression, but that does not make it an automatic first choice. The longer elimination period and different safety considerations require a prescriber-led decision.
Finasteride may be selected when hormonal control is the main treatment goal. Minoxidil may be useful when a non-hormonal follicular approach is preferred. Some dermatologists use both mechanisms in selected patients, balancing potential benefit against tolerability.
Finasteride is not suitable for everyone. The medication is not for you if:
You are a woman who is pregnant or may become pregnant and could handle crushed or broken tablets. Pregnant women must not handle crushed or broken finasteride pills because the active ingredient can interfere with development of male external genitalia. Intact tablets have a protective coating, but anyone who is pregnant should avoid handling damaged tablets.
Finasteride is not indicated for women with female pattern hair loss. It also does not treat sudden patchy hair loss, scarring alopecia, or hair loss caused by nutritional deficiency without addressing the underlying diagnosis.
Tell the prescriber about:
Finasteride is tolerated by many patients, but unwanted effects can occur. The side effects most relevant to men using it for hair loss involve sexual function.
Reported reactions include:
Clinical trials of the lower hair-loss regimen reported sexual adverse reactions in a small minority of participants, with rates varying between studies and treatment groups. The FDA prescribing information records decreased libido, erectile dysfunction, and ejaculation disorders among reported reactions [2].
Sexual symptoms often improve during continued treatment or after discontinuation, but persistent symptoms have also been reported. A new sexual symptom should be recorded with its timing, severity, and relationship to treatment rather than dismissed or assumed to be permanent.
Mood changes deserve attention. Contact a prescriber promptly if persistent sadness, loss of interest, marked anxiety, or thoughts of self-harm develop. Emergency help is needed for thoughts of suicide or immediate danger.
Breast tissue changes require medical assessment, especially if a lump, nipple discharge, or one-sided enlargement occurs. These symptoms are uncommon but should not be ignored.
Finasteride may rarely affect semen parameters. This matters for men being assessed for fertility. A semen analysis and medication review can help distinguish treatment effects from other causes of reduced fertility.
Several practical mistakes can reduce benefit or make side effects harder to interpret:
One overlooked detail is PSA interpretation. Finasteride can lower PSA, so a clinician must know about treatment before interpreting the result.
Another is the time scale. Hair cycles move slowly, and early shedding does not provide a reliable verdict on final response.
In clinical practice, doctors often set expectations around preservation before regrowth. Finasteride may stabilise hair loss without producing dramatic new coverage, especially when follicles have been miniaturised for many years.
A dermatologist usually assesses the pattern of thinning, family history, scalp examination, and the speed of progression. Sudden shedding, scalp inflammation, scarring, or loss of eyebrows suggests a different diagnostic pathway.
For prostate symptoms, doctors assess urinary flow, residual urine, infection symptoms, kidney function, and PSA when appropriate. Finasteride can reduce prostate-related obstruction, but it is not a substitute for evaluating blood in the urine, severe pain, fever, or acute inability to urinate.
The American Academy of Dermatology supports discussing established treatment options according to the pattern and cause of hair loss. The European Medicines Agency also recognises mood and sexual-function concerns as relevant counselling points for finasteride users [3].
Visible hair improvement usually requires several months of continuous treatment. Clinical studies and FDA-reviewed prescribing information assess hair response over longer periods rather than after a few days. A 2024 review of androgenetic alopecia treatment indexed in PubMed also supports using consistent photographic follow-up instead of daily visual judgement [4].
Finasteride can reduce DHT-driven prostate growth and improve urinary symptoms associated with benign prostatic hyperplasia. The European Medicines Agency's 2017 product information recognises 5-alpha reductase inhibition as the basis for this effect. Symptom relief develops gradually, and acute urinary retention still requires urgent medical care.
Erectile dysfunction and reduced libido are recognised adverse reactions, although they affect a minority of users in clinical studies. The FDA's 2017 prescribing information lists these events among possible treatment-related reactions. Symptoms should be reported with their timing, severity, and any change after treatment adjustment rather than ignored.
Pregnant women or women who may become pregnant should not handle crushed or broken finasteride tablets. The FDA's 2017 prescribing information identifies fetal exposure to finasteride as a safety concern during pregnancy. Intact tablets should still be stored responsibly so that damaged tablets are not handled accidentally.
Finasteride can reduce PSA readings, which may affect how a clinician interprets prostate-cancer screening or monitoring. The National Institute for Health and Care Excellence's 2023 guidance addresses medication history as part of appropriate PSA interpretation. Always state that finasteride is being used before a PSA test is assessed.
Finasteride and minoxidil act through different pathways and are sometimes used together under clinical supervision. The American Academy of Dermatology's 2024 guidance lists both as established approaches for selected patients with pattern hair loss. Combining them can increase treatment complexity, so each product should be monitored separately for adverse effects and adherence.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
The first change I noticed was less hair on my pillow. My hairline did not suddenly fill in, but the crown looked steadier in photographs after a few months. I had no sexual symptoms and kept taking the pill at breakfast.
I began treatment for thinning at the crown. Shedding seemed lower, although progress was difficult to judge without photographs. I experienced reduced libido during the first weeks and discussed it with my prescriber before deciding whether to continue.
I expected visible regrowth quickly and felt disappointed at first. The main benefit was that the recession appeared slower. Remembering the pill became easier when I kept it beside my morning water glass.
Urination improved gradually rather than overnight. I had to remind the clinic that I was taking finasteride before a PSA test. The urinary benefit mattered more to me than any hair-related effect.
I noticed changes in sexual interest and stopped taking the tablets without discussing it. Symptoms improved, but I later realised that documenting the timing would have helped the doctor assess the situation.
